Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and japanese populations: Implication for progressive supranuclear palsy

Neuroscience Letters

Volumn 250, Issue 2, 1998, Pages 135-137

  Conrad, Chris ^a   Amano, Naoji ^b   Andreadis, Athena ^c,d,e   Xia, Yu ^a   Namekataf, Kazuhiko ^h   Oyama, Fumitaka ^b   Ikeda, Kenji ^f   Wakabayashi, Koichi ^g   Takahashi, Hitoshi ^g   Thal, Leon J ^a   Katzman, Robert ^a   Shackelford, Deborah A ^a   Matsushita, Masaaki ^b   Masliah, Eliezer ^a   Sawa, Akira ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^g NIIGATA UNIVERSITY   (Japan)

^h NONE

Author keywords

Alzheimer's disease; Caucasian; Chromosome 17; Dinucleotide repeat; Exon 10; Intron; Japanese; Progressive supranuclear palsy; Tau

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASIAN; CHROMOSOME 17; DISEASE COURSE; EXON; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MARKER GENE; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RACE DIFFERENCE; SEQUENCE ANALYSIS;

ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 17; DINUCLEOTIDE REPEATS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; JAPAN; POLYMORPHISM, GENETIC; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0345627999     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00417-0     Document Type: Article

References (20)

1. Andreadis A., Brown W., Kosik K. Structure and novel exons of the human tau gene. Biochemistry. 31:1992;10626-10633.
2. Andreadis A., Broderick J.A., Kosik K.S. Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. Nucleic Acids Res. 23:1995;3585-3593.
3. Andreadis A., Nisson P.E., Kosik K.S., Watkins P.C. The exon trapping assay partly discriminates against alternatively spliced exons. Nucleic Acids Res. 21:1993;2217-2221.
4. Chen X., Xia Y., Gresham L., Molgaard C.A., Thomas R.G., Galasko D., Weiderholt W.C., Saitoh T. APOE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of chamorro. Guam, Neurology. 47:1996;779-784.
5. Conrad C., Andreadis A., Trojanowski J.Q., Dickson D.W., Kang D., Chen X., Weiderholt W.C., Hansen L., Masliah E., Thal L.J., Katzman R., Xia Y., Saitoh T. Genetic evidence for the involvement of τ in progressive supranuclear palsy. Ann. Neurol. 41:1997;277-281.
6. Delacourte A., Sergeant N., Wattez A., Gauvreau D., Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann. Neurol. 43:1998;193-204.
7. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol. 40:1996;139-148.
8. Flament S., Delacourte A., Verny M., Hauw J.J., Javoy-Agid F. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (Berl.). 81:1991;591-596.
9. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
10. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau; sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;526-529.
11. Golbe L., Davis P., Schoenberg B., Duvoisin R. Prevalence and natural history of progressive supranuclear palsy. Neurology. 28:1988;1031-1034.
12. Hecker K.H., Roux K.H. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques. 20:1996;478-485.
13. Higgins J.J., Litvan I., Pho L.T., Li W., Nee L.E. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology. 50:1998;270-273.
14. Kosik K.S. Tau protein and neurodegeneration. Mol. Neurobiol. 4:1990;171-179.
15. Sawa A., Oyama F., Matsushita M., Ihara Y. Molecular diversity at the carboxyl terminus of human and rat tau. Mol. Brain Res. 27:1994;111-117.
16. Sawa A., Amano N., Yamada N., Kajio H., Yagishita S., Takahashi T., Oda M., Arai N., Ikeda K., Tadokoro M., Matsushita M. Apolipoprotein E in progressive supranuclear palsy in Japan. Mol. Psychiatry. 2:1997;341-342.
17. Spillantini M.G., Goedert M., Crowther R.A., Murrell J.R., Farlow M.R., Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. (USA). 94:1997;4113-4118.
18. Trojanowski, J.Q., Clark, C.M., Schmidt, M.L., Arai, H., Zhu, C., Mawal-Dewan, M. and Lee, V. Implication of tau rich neurofibrillary lesions for the pathobiology and diagnosis of Alzheimer's disease. In S.H. Appel (Ed.), Current Neurology, Vol. 16, Houghton-Miffitin, Boston, MA, 1996, pp. 93-114.
19. Vermersch P., Sautiere P.E., Goudemand M., Delacourte A. General cortical involvement in a late-onset case of Alzheimer disease. A biochemical approach by quantitation of abnormal tau proteins. Mol. Chem. Neuropathol. 18:1993;213-224.
20. de Yebenes J.G., Sarasa J.L., Daniel S.E., Lees A.J. Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain. 118:1995;1095-1103.